Unbiased AI-powered news
Israeli forces conducted over 50 strikes across Lebanon in the past 24 hours, including attacks on residential areas in southern towns. These actions followed a Hezbollah rocket response and occurred days after the start of a US-Israel war on Iran. The United Nations has reported rising displacement and food security issues affecting over one million people, including nearly 390,000 children.
Al JazeeraThe United Nations World Food Programme has warned of a developing food security crisis in Lebanon alongside displacement issues.
Food prices have risen, making supplies less affordable amid increased demand from displaced families and disruptions from the war on Iran. Officials stated that the situation is rapidly becoming a food security crisis.
“What we’re witnessing is not just a displacement crisis, it is rapidly becoming a food security crisis.”
Reports indicate that escalating attacks have affected children severely. Reports also include children missing, separated from families, or recovered from rubble.
A senior Lebanese official indicated plans to join a meeting with US and Israeli representatives to discuss a ceasefire. Officials view this as a precondition for broader talks with Israel, though sources indicated that the meeting will be preparatory rather than a full negotiation.
The violence escalated after Israel and the US launched a war on Iran. Hezbollah attacked Israel, prompting Israel's air campaign and ground operations in southern Lebanon.
The ceasefire between the US and Iran faces uncertainty amid these developments.
Single source — no framing comparison available.
dailywire.comThe Food and Drug Administration approved enlicitide, sold as Lipfendra, a once-daily oral drug that inhibits PCSK9. The medication will be available in a few weeks at a list price of $315 for a 30-day supply.
indianexpress.comEli Lilly will pay $2.8 billion in cash to acquire AtaiBeckley, a developer of psychedelic treatments for mental health conditions. The deal includes up to $1 billion in additional milestone payments. It adds the target’s compounds to Lilly’s neuroscience programs.
news.ycombinator.comKalshi will allow bets on selected clinical trial results and full FDA decisions, starting with Phase 3 studies from established companies. The FDA separately approved Merck's Lipfendra cholesterol pill based on studies showing up to 60% LDL reduction.